DeFi expert Jim Bianco joins Jared Blikre to break down an interesting year ahead on Wednesday, 1/12 at 2PM ET.
Firm Further Bolsters Senior Health Bench with Appointment of Erin Davis to EVP, Government Health Growth and Strategy
NEW YORK, Jan. 11, 2022 /PRNewswire/ — Reflecting its reputation as a destination for top healthcare talent, leading communications consultancy Ketchum today announced the hires of Samantha Schwarz as Managing Director and Health Portfolio Leader to lead its North America health business. She joins the consultancy from Novartis, where she served as Senior Director, Corporate Communications, Novartis Gene Therapies.
Recognized as a Top Women in Healthcare by PR News, Schwarz brings 25 years of experience in health communications, including 15 years at Golin, where she last held the position of Chicago Healthcare Practice Lead. She will oversee the entire health sector for Ketchum, which services clients across all health industries including pharmaceuticals, biotech, medical device, consumer health, hospitals and health systems, payers and government health. Reporting into North America President Neera Chaudhary, Schwarz will drive the consultancy's strategic direction in health, provide commercial and thought leadership, and lead its acquisition strategy.
"The critical role of health and healthcare in our society has never been more celebrated than it is right now, and the demand for continuous innovation, education and communication is increasing at an exponential rate. That's why Ketchum is hyper-focused on health and investing in top talent whose expertise spans the full health ecosystem," said Chaudhary.
She continued, "When it comes to pharma and biotech experience, Sam Schwarz's list of impressive accolades is extensive, and having previously worked with her closely, I know that it is her real instinct for building teams and growing client relationships that will make her a tremendous asset for Ketchum."
Schwarz most recently led global and U.S. product communications for the most widely used gene therapy globally, supporting one of Novartis' most successful launches to date. In this role, she led announcements for regulatory approvals in global markets, multiple data milestones and clinical program updates, value and access communications, and developed a powerful patient storytelling engine to bring to life the impact of gene therapy on the spinal muscular atrophy community. In addition, she was a key leader on issues management and investor relations support and helped to establish a corporate social strategy and presence.
Previously, she led the Chicago Healthcare Practice at Golin, delivering strategic communications and tactical excellence for a diverse client portfolio, ranging from some of the world's most recognized pharmaceutical and biotechnology companies to payers, health service organizations, hospital systems and health tech startups.
"Ketchum's well-established consultancy model, combined with its diverse health portfolio and depth of talent, inspired my decision to return to the agency side. Additionally, the firm's culture naturally lends itself to some of the most important corporate attributes during these times – continuity with flexibility, authenticity and a passion to make a difference," said Schwarz. "I'm energized by the opportunity to apply learnings from my experience at Novartis, including partnering with multiple communications agencies, to help develop teams and strategic programming uniquely suited to meet the specific needs of Ketchum's health clients. I'm looking forward to working closely with my team to establish and deliver on the consultancy's strategic direction in health."
Ketchum also appointed Erin Davis as EVP, Government Health Growth and Strategy, reporting into Michelle Baker, Chief of Staff, Health. She brings 18 years of experience of strategic planning, communication, organizational change management and information technology transformation projects for federal and commercial customers. Most recently, Davis was Senior Associate for Booz Allen Hamilton, where she worked for more than 11 years supporting federal government contracts focused on health.
Chaudhary said, "Ketchum's healthcare portfolio has grown tremendously with the addition of new clients and with the ever-changing needs of our current clients in this sector, and this momentum isn't slowing. We pride ourselves as a communications consultancy whose health capabilities span the full healthcare ecosystem and across other sectors where health increasingly is a business priority. With the addition of these world-class leaders, we're adding tremendous expertise and value for our clients, and further cementing our reputation as the leading destination for health clients and top talent."
These latest hires come on the heels of the launch of the firm's health equity offering, HEq, late last year. In 2021, Ketchum made significant investments in health equity leaders, hiring Valarie Clark as SVP, Health Equity, focused on helping clients deliver healthcare to the individuals and communities that need it the most, and hiring Nicky Battle as EVP of Health Consumer Experience, leading inclusive design and ensuring accessible and impactful communications experience for health consumers.
The winner of 131 Cannes Lions and PRovoke's Global Creative Agency of the Year, Ketchum is the most creatively awarded firm in our industry. We're equal parts human-centered and business-focused, empathetic and intelligent. As a global communications consultancy, we combine the deep industry and specialty expertise of boutique firms with global reach to find unexpected connections that lead to lasting relationships and work that matters. For more information on Ketchum, a part of Omnicom Public Relations Group, visit www.ketchum.com.
About Omnicom Public Relations Group
Omnicom Public Relations Group is a global collective of three of the top global public relations agencies worldwide and specialist agencies in areas including public affairs, language strategy, global health strategy and change management. As the largest group of communications professionals in the world, our employees provide expertise to companies, government agencies, NGOs and nonprofits across a wide range of industries. Omnicom Public Relations Group delivers for clients through a relentless focus on talent, continuous pursuit of innovation and a culture steeped in collaboration. Omnicom Public Relations Group is part of the Communications Consultancy Network, a division of Omnicom Group Inc. (NYSE: OMC).
About Communications Consultancy Network
Communications Consultancy Network (CCN) is a global collective of the top global public relations, strategy, branding, and research agencies. Award-winning brands include FleishmanHillard, Ketchum, Porter Novelli, Marina Maher Communications, Interbrand, C Space, Wolff Olins, Sterling, Siegel & Gale and Hall & Partners. We are home to a group of highly talented and specialized consultants across industries and marketing disciplines, delivering strategic thinking and market-leading innovation to clients. CCN is a division of Omnicom Group Inc. (NYSE: OMC).
About Omnicom Group Inc.
Omnicom Group Inc. (NYSE: OMC) (www.omnicomgroup.com) is a leading global marketing and corporate communications company. Omnicom's branded networks and numerous specialty firms provide advertising, strategic media planning and buying, digital and interactive marketing, direct and promotional marketing, public relations and other specialty communications services to over 5,000 clients in more than 70 countries. Follow us on Twitter for the latest news.
View original content:https://www.prnewswire.com/news-releases/ketchum-hires-samantha-schwarz-as-leader-of-north-america-health-portfolio-301458586.html
Cathie Wood, the star fund manager and chief executive of ARK Invest, in a Tuesday monthly market update says that the used car market is where she is expecting possible losses after a surge in values.
AMSTERDAM (Reuters) -Philips shares plunged more than 11% on Wednesday morning after the Dutch health technology company hiked the cost of its massive recall of ventilators and said earnings would take a big hit from global supply chain shortages. Comparable sales fell 10% on a yearly basis to 4.9 billion euros, Philips said, as hospitals had to postpone the installation of equipment due to a lack of parts. Van Houten said the supply chain problems had intensified over the fourth quarter, and were not expected to disappear in the first months of 2022.
(Bloomberg) — A gauge of Chinese technology shares rallied by the most in three months as investors took advantage of attractive valuations in the battered sector and the prospect of looser monetary policy conditions.Most Read from BloombergEU Warns Repeat Boosters Could Weaken Immune SystemEurope Slowly Starts to Consider Treating Covid Like the FluCypriot Scientist Says Deltacron Covid Variant Isn’t ErrorWorld’s Worst-Performing Bank Lent Billions to China EvergrandeDjokovic Admits Doing Phot
There are thousands of publicly traded companies out there, and they all send out a range of signals that investors must learn to interpret. Parsing these signals is essential for investing success, and having a clear strategy, based on reliable market indicators, often makes the difference between gaining or losing in the market. One of the clearest signals that retail investors can follow is the buying patterns of corporate insiders. These are the company officers who hold high positions – CEO
The Wall Street giant really likes these dividend stocks — for very good reasons.
The start of a new year is always a convenient time to evaluate, or reevaluate, the stock portfolios. With a year’s worth of data behind us, and fresh forecasts ahead, investors can use the fresh start on the calendar to figure out if they need a rethink on their investment strategy. In a note from Morgan Stanley, chief investment officer Mike Wilson defines the key question for investors now as a simple binary decision, between staying with relative winners or going ‘bottom fishing.’ Each has i
Many stocks in the electric vehicle (EV) sector have been in correction mode over the last month. The shares of Chinese EV maker Nio (NYSE: NIO) have been no exception, dropping more than 12% over the past four weeks. Nio shares remained up 3.3% as of 11 a.m. ET.
Finra has ordered the zero-commission app Robinhood to pay Jose Batista almost $30K and found the company liable for his investment losses when it restricted trading on meme stocks in Jan 2021.
If you're looking for some worthwhile growth stocks to buy and hold through the storm, you've come to the right place. Lithium Americas (NYSE: LAC), ChargePoint Holdings (NYSE: CHPT), and Cognex Corporation (NASDAQ: CGNX) are three growth stocks that could be good buys in January. Scott Levine (Lithium Americas): If you're like most growth investors, you've undoubtedly come across plenty of ink spilled about electric vehicles since the market is expected to grow considerably over the next decade.
Shares of electric heavy-truck start-up Nikola (NASDAQ: NKLA) were trading higher on Tuesday, after the company announced that Covenant Logistics Group (NASDAQ: CVLG) has signed a letter of intent to buy 50 of Nikola's electric semi trucks, if a test program goes well. As of 11:15 a.m. ET today, Nikola's shares were up about 5.1% from Monday's closing price. Nikola said that Covenant Logistics, a long-haul trucking firm based in Chattanooga, Tennessee, has agreed to purchase 10 battery-electric (BEV) Tre semis, and 40 fuel-cell-powered (FCEV) Tres, once a demonstration program has been completed to both companies' satisfaction.
JPMorgan Chase & Co. CEO Jamie Dimon says the consumer remains in great shape in 2022 but also said that volatility could be elevated in financial markets as the Federal Reserve aims to navigate a COVID-induced surge in inflation.
The stock of Pacific Biosciences of California (NASDAQ: PACB), a company developing DNA sequencing machines, is losing ground after an investor update. Preliminary fourth-quarter sales figures missed expectations, driving the stock 11.8% lower as of 12:54 p.m. ET on Tuesday. Preliminary sales figures from the fourth quarter weren't bad, but they were slightly less than the market was expecting.
After days of declines, a large number of e-commerce and technology stocks staged a wide-ranging relief rally on Tuesday. Investors focused on a broader range of economic issues, allowing high-growth stocks to stage a comeback. E-commerce platforms have taken it on the chin recently, as investors bet that massive gains resulting from the pandemic would eventually fade.
Here's another cold, hard truth that many proponents of penny stocks don't tell you: Many low-priced shares stay low for a very long time.
Several top U.S. oil stocks are in buy range Tuesday as oil prices rise amid OPEC+ production disruptions.
The Dow Jones rose after Fed chair Jerome Powell made an inflation pledge. Tesla stock is offering a new opportunity. GE stock jumped.
Citi analysts believe the merger of Discovery and AT&T's WarnerMedia will be an important catalyst for AT shares.
Lemonade is still more than 75% below its all-time high even after today's bounce. Instead, there's a massive rally happening in high-growth tech stocks that have been beaten down in recent months, and Lemonade certainly belongs to this group. Fears about inflation and rising interest rates have weighed on speculative stocks recently, and the benchmark 10-Year Treasury yield has pulled back significantly from its peak, so it seems to be calming investors down.
Canadian cannabis company Tilray (NASDAQ: TLRY) reported its fiscal 2022 second-quarter earnings results yesterday, and its shares soared. The company surprised investors with a profitable quarter and strong revenue growth. Today, Tilray peer Organigram Holdings (NASDAQ: OGI) also reported solid quarterly results.
Shares of the blank check company Digital World Acquisition Corp (NASDAQ: DWAC) rose 14% today for no apparent reason. As a special purpose acquisition company (SPAC), Digital World Acquisition Corp went public with the intent of acquiring a private business to bring it public. In late October, the SPAC announced that it intended to merge with and take public Trump Media & Technology Group, the parent of TRUTH Social.